Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 3Genitourinary 3Other solid neoplasm 2Gastrointestinal 2Gynecologic 1

Conditions

Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Neuroectodermal Tumors 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Glioma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3pembrolizumab 2Radiosurgery 2Paclitaxel 2Nivolumab 2Ipilimumab 2FAPI-46 2tipifarnib 1sodium thiosulfate 1sargramostim 1regorafenib 1montelukast 1entrectinib 1entinostat 1cediranib 1cc-486 1carboxyamido-triazole 1alectinib 1aflibercept 1Trastuzumab 1Thiotepa 1Tablets 1Specimen Handling 1Sirolimus 1Sevoflurane 1Ritonavir 1Restraint, Physical 1Radiotherapy 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Busulfan × Gynecologic × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡